{
    "organizations": [],
    "uuid": "05aba25b80653d4e54f54f187b202edaf8c488a3",
    "author": "",
    "url": "https://www.reuters.com/article/brief-amgen-receives-positive-chmp-opini/brief-amgen-receives-positive-chmp-opinion-for-delivery-system-of-neulasta-idUSFWN1QH13P",
    "ord_in_thread": 0,
    "title": "BRIEF-Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 27, 2018 / 2:29 PM / in 10 minutes BRIEF-Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta Reuters Staff Feb 27 (Reuters) - Amgen Inc: * AMGEN RECEIVES POSITIVE CHMP OPINION FOR DELIVERY SYSTEM OF NEULASTAÂ® (PEGFILGRASTIM) * AMGEN INC - CHMP OF EMA ISSUED A POSITIVE OPINION RECOMMENDING A LABEL VARIATION FOR NEULASTA TO INCLUDE NEULASTA ONPRO KIT Source text for Eikon: Further company coverage:",
    "published": "2018-02-27T16:27:00.000+02:00",
    "crawled": "2018-02-27T16:42:10.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "receives",
        "positive",
        "chmp",
        "opinion",
        "delivery",
        "system",
        "neulasta",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "amgen",
        "inc",
        "amgen",
        "receives",
        "positive",
        "chmp",
        "opinion",
        "delivery",
        "system",
        "pegfilgrastim",
        "amgen",
        "inc",
        "chmp",
        "ema",
        "issued",
        "positive",
        "opinion",
        "recommending",
        "label",
        "variation",
        "neulasta",
        "include",
        "neulasta",
        "onpro",
        "kit",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}